EP Patent

EP1601658A1 — Crystalline ammonium salts of rosuvastatin

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2005-12-07 · 20y expired

What this patent protects

Provided are alkyl ammonium crystalline salts of rosuvastatin that provide for purification of rosuvastatin and its pharmaceutically acceptable salts.

USPTO Abstract

Provided are alkyl ammonium crystalline salts of rosuvastatin that provide for purification of rosuvastatin and its pharmaceutically acceptable salts.

Drugs covered by this patent

Patent Metadata

Patent number
EP1601658A1
Jurisdiction
EP
Classification
—
Expires
2005-12-07
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.